New advances in the treatment of generalized lipodystrophy: Role of metreleptin
Recombinant methionyl human leptin or metreleptin is a synthetic leptin analog that has been trialed in patients with leptin-deficient conditions, such as leptin deficiency due to mutations in the leptin gene, hypothalamic amenorrhea, and lipodystrophy syndromes. These syndromes are characterized by partial or complete absence of adipose tissue and hormones derived from adipose tissue, most importantly leptin. Patients deficient in leptin exhibit a number of severe metabolic abnormalities such...[Show more]
|Collections||ANU Research Publications|
|Source:||Therapeutics and Clinical Risk Management|
|Access Rights:||Open Access|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.